Table II.
Univariate and multivariate Cox regression survival analyses of the prognostic factors of glioma.
| Overall survival | ||||||
|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | |||||
| Clinical parameter | HR | 95% CI | P-value | HR | 95% CI | P-value |
| TPTEP1 expression (low vs. high) | 2.572 | (1.516–4.366) | <0.001 | 2.143 | (1.062–3.554) | 0.031 |
| Age, years (≤median vs. >median) | 0.481 | (0.287–0.808) | 0.007 | 0.590 | (0.331–1.054) | 0.075 |
| Sex (female vs. male) | 0.660 | (0.389–1.119) | 0.118 | 0.736 | (0.407–1.330) | 0.310 |
| WHO grade (I–II vs. III–IV) | 0.073 | (0.041–0.128) | <0.001 | 0.427 | (0.238–0.821) | 0.010 |
| Recurrence (no vs. yes) | 0.095 | (0.056–0.161) | <0.001 | 0.485 | (0.269–0.974) | 0.043 |
TPTEP1, transmembrane phosphatase with tensin homology pseudogene 1; WHO, World Health Organization; HR, hazard ratio; CI, confidence interval.